+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Blood Collection Devices Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Tubes Type, By Plasma/whole-blood Tubes Type, By Tubes System Type, By Method, By Application, By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 140 Pages
  • February 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5571062
The Latin America, Middle East and Africa Blood Collection Devices Market is expected to witness market growth of 8.0% CAGR during the forecast period (2021-2027).

Capital investments in automated blood collection utilizing apheresis devices are high. Blood sampling or blood collection is an important aspect of diagnosing different diseases. It does not just help in tracking down the data on the excess or lack of various components in the body yet it is the first step in diagnosing any infection in the body. The hospitals and medical facilities have a wide range of blood collection systems. Whereas, there are three main ways through which blood can be collected from the patients, among which, Veinipunctures is the most commonly performed procedure.

Minimal fluid biopsy attacks are a nice method for identifying the genomic feature of DNA tumors, especially in pediatric oncology.  Rising investment for product development will support the commercialization of blood collection tubes for liquid biopsy capable of incorporating in applications like PCR, NGS & DNA methylation assays.

Approximately 60% of the African children with the age of 5 or less are suffering from anemia. The prevalence of anemia in the sub-Saharan Africa region in preschool children is 42% in Swaziland to 91% in Burkina Faso. Also, 49.7% of married women in the region have anemia. The average rate of voluntary non remunerated blood donations was 67%. The lowest rate of blood donation was in Central Africa that is 34.4%.

Besides this, the percentage of reactive blood units to transfusion-transmitted infections was 4,2% of hepatitis B virus 1.3% for HIV, and 1.0% for hepatitis C virus. The cancer incidence rate is anticipated to reach 340 & 296 per 100,000 females & males simultaneously in Lebanon in 2018. This is expected to arise the need for blood tests & collection in the LAMEA region which is likely to support the growth of the blood collection device market in this region.

The Brazil market dominated the LAMEA Blood Collection Devices Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $175.3 million by 2027. The Argentina market is poised to grow at a CAGR of 8.6% during (2021 - 2027). Additionally, The UAE market is expected to exhibit a CAGR of 7.7% during (2021 - 2027).

Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, & Nursing Homes; Diagnostic & Pathology Laboratories, Blood Banks and Others. Based on Product, the market is segmented into Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors and Lancets. Based on Tubes Type, the market is segmented into Plasma/whole-blood Tubes and Serum Tubes. Based on Plasma/whole-blood Tubes Type, the market is segmented into EDTA Tubes, Heparin Tubes, Coagulation Tubes, Glucose Tubes and Others. Based on Tubes System Type, the market is segmented into Vacuum Tubes and Non-Vacuum Tubes. Based on Method, the market is segmented into Manual Blood Collection and Automatic Blood Collection. Based on Application, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sarstedt AG & Company, ICU Medical, Inc., Grifols, S.A., Retractable Technologies, Inc., Quest Diagnostics Incorporated, Becton, Dickinson and Company, Haemonetics Corporation, Terumo Corporation, Fresenius SE & Co. KGaA, and Cardinal Health, Inc.

Scope of the Study


Market Segments Covered in the Report:


By End User
  • Hospitals, Ambulatory Surgical Centers, & Nursing Homes
  • Diagnostic & Pathology Laboratories
  • Blood Banks
  • Others

By Product
  • Blood Collection Tubes
  • Needles & Syringes
  • Blood Bags
  • Blood Collection Systems/Monitors
  • Lancets

By Tubes Type
  • Plasma/whole-blood Tubes
  • Serum Tubes

By Plasma/whole-blood Tubes Type
  • EDTA Tubes
  • Heparin Tubes
  • Coagulation Tubes
  • Glucose Tubes
  • Others

By Tubes System Type
  • Vacuum Tubes
  • Non-Vacuum Tubes

By Method
  • Manual Blood Collection
  • Automatic Blood Collection

By Application
  • Diagnostics
  • Therapeutics

By Country: Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Key Market Players


List of Companies Profiled in the Report:

  • Sarstedt AG & Company
  • ICU Medical, Inc.
  • Grifols, S.A.
  • Retractable Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Becton, Dickinson and Company
  • Haemonetics Corporation
  • Terumo Corporation
  • Fresenius SE & Co. KGaA
  • Cardinal Health, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Blood Collection Devices Market, by End User
1.4.2 LAMEA Blood Collection Devices Market, by Product
1.4.3 LAMEA Blood Collection Devices Market, by Tubes Type
1.4.4 LAMEA Blood Collection Devices Market, by Plasma/whole-blood Tubes Type
1.4.5 LAMEA Blood Collection Devices Market, by Tubes System Type
1.4.6 LAMEA Blood Collection Devices Market, by Method
1.4.7 LAMEA Blood Collection Devices Market, by Application
1.4.8 LAMEA Blood Collection Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
Chapter 4. LAMEA Blood Collection Devices Market by End User
4.1 LAMEA Hospitals, Ambulatory Surgical Centers, & Nursing Homes Market by Country
4.2 LAMEA Diagnostic & Pathology Laboratories Market by Country
4.3 LAMEA Blood Banks Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA Blood Collection Devices Market by Product
5.1 LAMEA Blood Collection Tubes Market by Country
5.2 LAMEA Blood Collection Tubes Market by Type
5.2.1 LAMEA Plasma/whole-blood Tubes Market by Country
5.2.2 LAMEA Plasma/whole-blood Tubes Market by Type
5.2.2.1 LAMEA EDTA Tubes Market by Country
5.2.2.2 LAMEA Heparin Tubes Market by Country
5.2.2.3 LAMEA Coagulation Tubes Market by Country
5.2.2.4 LAMEA Glucose Tubes Market by Country
5.2.2.5 LAMEA Others Market by Country
5.2.3 LAMEA Serum Tubes Market by Country
5.3 LAMEA Blood Collection Tubes Market by System Type
5.3.1 LAMEA Vacuum Tubes Market by Country
5.3.2 LAMEA Non-Vacuum Tubes Market by Country
5.4 LAMEA Needles & Syringes Market by Country
5.5 LAMEA Blood Bags Market by Country
5.6 LAMEA Blood Collection Systems/Monitors Market by Country
5.7 LAMEA Lancets Market by Country
Chapter 6. LAMEA Blood Collection Devices Market by Method
6.1 LAMEA Manual Blood Collection Market by Country
6.2 LAMEA Automatic Blood Collection Market by Country
Chapter 7. LAMEA Blood Collection Devices Market by Application
7.1 LAMEA Diagnostics Market by Country
7.2 LAMEA Therapeutics Market by Country
Chapter 8. LAMEA Blood Collection Devices Market by Country
8.1 Brazil Blood Collection Devices Market
8.1.1 Brazil Blood Collection Devices Market by End User
8.1.2 Brazil Blood Collection Devices Market by Product
8.1.2.1 Brazil Blood Collection Tubes Market by Type
8.1.2.1.1 Brazil Plasma/whole-blood Tubes Market by Type
8.1.2.2 Brazil Blood Collection Tubes Market by System Type
8.1.3 Brazil Blood Collection Devices Market by Method
8.1.4 Brazil Blood Collection Devices Market by Application
8.2 Argentina Blood Collection Devices Market
8.2.1 Argentina Blood Collection Devices Market by End User
8.2.2 Argentina Blood Collection Devices Market by Product
8.2.2.1 Argentina Blood Collection Tubes Market by Type
8.2.2.1.1 Argentina Plasma/whole-blood Tubes Market by Type
8.2.2.2 Argentina Blood Collection Tubes Market by System Type
8.2.3 Argentina Blood Collection Devices Market by Method
8.2.4 Argentina Blood Collection Devices Market by Application
8.3 UAE Blood Collection Devices Market
8.3.1 UAE Blood Collection Devices Market by End User
8.3.2 UAE Blood Collection Devices Market by Product
8.3.2.1 UAE Blood Collection Tubes Market by Type
8.3.2.1.1 UAE Plasma/whole-blood Tubes Market by Type
8.3.2.2 UAE Blood Collection Tubes Market by System Type
8.3.3 UAE Blood Collection Devices Market by Method
8.3.4 UAE Blood Collection Devices Market by Application
8.4 Saudi Arabia Blood Collection Devices Market
8.4.1 Saudi Arabia Blood Collection Devices Market by End User
8.4.2 Saudi Arabia Blood Collection Devices Market by Product
8.4.2.1 Saudi Arabia Blood Collection Tubes Market by Type
8.4.2.1.1 Saudi Arabia Plasma/whole-blood Tubes Market by Type
8.4.2.2 Saudi Arabia Blood Collection Tubes Market by System Type
8.4.3 Saudi Arabia Blood Collection Devices Market by Method
8.4.4 Saudi Arabia Blood Collection Devices Market by Application
8.5 South Africa Blood Collection Devices Market
8.5.1 South Africa Blood Collection Devices Market by End User
8.5.2 South Africa Blood Collection Devices Market by Product
8.5.2.1 South Africa Blood Collection Tubes Market by Type
8.5.2.1.1 South Africa Plasma/whole-blood Tubes Market by Type
8.5.2.2 South Africa Blood Collection Tubes Market by System Type
8.5.3 South Africa Blood Collection Devices Market by Method
8.5.4 South Africa Blood Collection Devices Market by Application
8.6 Nigeria Blood Collection Devices Market
8.6.1 Nigeria Blood Collection Devices Market by End User
8.6.2 Nigeria Blood Collection Devices Market by Product
8.6.2.1 Nigeria Blood Collection Tubes Market by Type
8.6.2.1.1 Nigeria Plasma/whole-blood Tubes Market by Type
8.6.2.2 Nigeria Blood Collection Tubes Market by System Type
8.6.3 Nigeria Blood Collection Devices Market by Method
8.6.4 Nigeria Blood Collection Devices Market by Application
8.7 Rest of LAMEA Blood Collection Devices Market
8.7.1 Rest of LAMEA Blood Collection Devices Market by End User
8.7.2 Rest of LAMEA Blood Collection Devices Market by Product
8.7.2.1 Rest of LAMEA Blood Collection Tubes Market by Type
8.7.2.1.1 Rest of LAMEA Plasma/whole-blood Tubes Market by Type
8.7.2.2 Rest of LAMEA Blood Collection Tubes Market by System Type
8.7.3 Rest of LAMEA Blood Collection Devices Market by Method
8.7.4 Rest of LAMEA Blood Collection Devices Market by Application
Chapter 9. Company Profiles
9.1 Sarstedt AG & Company
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Acquisition and Mergers
9.2 ICU Medical, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.3 Grifols, S.A
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.4 Retractable Technologies, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental Analysis
9.4.4 Research & Development Expenses
9.5 Quest Diagnostics Incorporated
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 Becton, Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Haemonetics Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expenses
9.8 Terumo Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Partnerships, Collaborations, and Agreements:
9.8.4.2 Product Launches and Product Expansions:
9.8.4.3 Geographical Expansions:
9.9 Fresenius SE & Co. KGaA
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. Cardinal Health, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis

Companies Mentioned

  • Sarstedt AG & Company
  • ICU Medical, Inc.
  • Grifols, S.A.
  • Retractable Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Becton, Dickinson and Company
  • Haemonetics Corporation
  • Terumo Corporation
  • Fresenius SE & Co. KGaA
  • Cardinal Health, Inc.

Methodology

Loading
LOADING...